Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
17.23
-0.32 (-1.82%)
At close: Jun 26, 2026, 4:00 PM EDT
17.27
+0.04 (0.23%)
After-hours: Jun 26, 2026, 7:56 PM EDT
Aurinia Pharmaceuticals Employees
Aurinia Pharmaceuticals had 128 employees as of December 31, 2025. The number of employees decreased by 2 or -1.54% compared to the previous year.
Employees
128
Change (1Y)
-2
Growth (1Y)
-1.54%
Revenue / Employee
$2,330,430
Profits / Employee
$2,329,789
Market Cap
2.22B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AbCellera Biologics | 562 |
| Agios Pharmaceuticals | 540 |
| Ocular Therapeutix | 325 |
| Kardigan | 241 |
| Immunome | 206 |
| Kodiak Sciences | 130 |
| Mineralys Therapeutics | 76 |
| Nektar Therapeutics | 63 |
AUPH News
- 23 days ago - Aurinia presents new analysis of AURORA 1 Phase 3 study of Lupkynis - TheFly
- 23 days ago - LUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or Death - Business Wire
- 23 days ago - Aurinia Pharmaceuticals up 4% in pre-market after insider transactions - TheFly
- 7 weeks ago - Aurinia Pharmaceuticals reports Q1 EPS 25c, consensus 20c - TheFly
- 7 weeks ago - Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026 and Provides Update on Recent Business Progress - Business Wire
- 7 weeks ago - Aurinia Pharmaceuticals Earnings release: Q1 2026 - Filings
- 7 weeks ago - Aurinia Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 2 months ago - Aurinia Pharmaceuticals Proxy statement: Proxy filing - Filings